CClinicalTrials.gg
CompletedNCT00804518Updated Jul 18, 2016

Effect of Exercise on Heart Function in Healthy Elderly People

An interventional study of Aerobic interval training in Diastolic Dysfunction, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 70 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-07-18.

Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Not applicable
Ages
70 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine the effect of aerobic interval training on left- and right ventricular diastolic- and systolic function on healthy, sedate people over 70 years. The old sedate cohort will be compared to young, sedate subjects also performing aerobic interval training and old master athletes without intervention.

Read the detailed description

Aging is associated with a reduced diastolic and systolic function of the heart. Earlier studies have shown that physical exercise can improve both systolic and diastolic function. However the impact on age-related cardiac function is to some extent conflicting. The use of different training intensities will impact on the cardiac result. We have in earlier studies shown aerobic interval training at 90 % of maximal heart rate (4x4 minutes) to have more impact on cardiac function, endothelial function and maximal oxygen uptake compared to moderate intensity.

To our knowledge the effect of aerobic interval training on cardiac function has not been studied in an old, sedate group before.

02

Conditions studied

  • Diastolic Dysfunction

Keywords

  • Aging
  • Diastolic dysfunction
  • Systolic function
  • Exercise
  • Echocardiography
  • tissue Doppler imaging
  • Cardiac function
03

In context

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • over 70 years, healthy
  • not exercising more than twice per week

Exclusion criteria

Exclusion Criteria:

  • chronic illness
  • chronic use of any medication
  • regular smoking
  • metabolic or cardiovascular diseases
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
45 participants (actual)

Study arms

  • Experimental
    Exercise intervention

    Other: Aerobic interval training

Interventions

  • OtherAerobic interval training

    High intensity aerobic interval training consists of 10 minutes warm up at \~60% of maximal heart rate, 4x4 minutes intervals at 90-95 % of maximal heart rate corresponding to 85-90% of VO2max) walking/running uphill on a treadmill, with three minutes active pause between the exercise bouts at 60-70% maximal heart rate. The session is terminated with 3 minutes cool down. Total exercise time is 38 minutes.The training is supervised by an exercise physiologist and the subjects train 3 times per week for 12 weeks.

06

What researchers measure

Primary outcomes

  1. Improvement of left and right ventricular early diastolic tissue velocity at rest and sub maximal exercise ,e'.

    Time frame: 12 weeks

Secondary outcomes

  1. Improvement of left and right ventricular systolic tissue velocity function at rest and sub maximal exercise, S'.

    Time frame: 12weeks

07

Study locations

1 site
  • Ntnu/Dmf/Isb
    Trondheim, Sør-Trøndelag 7489, Norway
08

References and documents

Publications

  • Molmen HE, Wisloff U, Aamot IL, Stoylen A, Ingul CB. Aerobic interval training compensates age related decline in cardiac function. Scand Cardiovasc J. 2012 Jun;46(3):163-71. doi: 10.3109/14017431.2012.660192. Epub 2012 Feb 20. PubMed 22273242 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 18, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00804518
Lead sponsor
Norwegian University of Science and Technology
Responsible party
Sponsor
First posted
Dec 9, 2008
Start date
Nov 2008
Primary completion
Mar 2009
Completion
Aug 2009
Last update
Jul 18, 2016

Study contacts

Charlotte Bjork Ingul, PhD
principal investigator · National Taiwan Normal University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion